Brief: Inmune Bio Inc. Achieves Mhra Approval Of Pip For Cordstrom™
25/06/2026 12:22
BRIEF-Inmune Bio Inc. Achieves Mhra Approval Of Pip For Cordstrom™ June 25 (Reuters) - INmune Bio Inc INMB.O:
INMUNE BIO INC. ACHIEVES MHRA APPROVAL OF PIP FOR CORDSTROM™
INMUNE BIO - UK MHRA APPROVES PEDIATRIC INVESTIGATION PLAN FOR EBSTROCEL FOR RDEB
INMUNE BIO - PREPARING FOR MAA SUBMISSION AND FINAL MANUFACTURING FOR EBSTROCEL
Source text: ID:nGNX1JW2pR
Further company coverage: INMB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inmune Bio
See all newsBrief: Inmune Bio - Enters Master Services Agreement With Uniphar For Ebstrocel International Commercialization
Brief: Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027
INmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary
INmune Bio Q2 net loss narrows on lower impairment charges
INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview